WordenA.N., & Lane-PetterW. eds (1957). The UFAW Handbook on the Care and Management of Laboratory Animals, 2nd edn, 951 pp. London, UK: UFAW.
2.
RussellW.M.S., & BurchR.L. (1959). The Principles of Humane Experimental Technique, 238 pp. London, UK: Methuen.
3.
CervinkaM. (1995). Alternatives in research and testing at the Department of Biology, Charles University Medical Faculty, Hradec Králové. In Alternatives to Animal Experimentation (ed. CervinkaM., & BallsM.), pp. 65–66. Hradec Králové, Czech Republic: Nucleus HK for Tempus JEP 1485.
4.
HofstadterD. (1980). Gödel, Escher, Bach: An Eternal Golden Braid, 777 pp. Harmondsworth, UK: Penguin Books.
5.
BallsM., & FentemJ.H. (1994). The Fund for the Replacement of Animals in Medical Experiments (FRAME): 23 years of campaigning for the Three Rs. In Alternatives to Animal Testing (ed. ReinhardtC.A.), pp. 45–55. Weinheim, Germany: VCH Publishers.
6.
BallsM. (1995). Acceptance of the Three Rs concept: a battle won. ATLA23, 1–3.
HegartyT. (1995). Dorothy Hegarty and the founding of FRAME: a personal recollection. ATLA23, 15–17.
9.
AnnettB. (1995). The Fund for the Replacement of Animals in Medical Experiments (FRAME): the first 25 years. ATLA23, 19–32.
10.
BallsM. (1995). On keeping your eyes on the prize: Dorothy Hegarty and acceptance of the concept of replacement of laboratory animal procedures in research, education and testing. ATLA23, 756–774.
11.
UngarK. (1997). A bibliometric evaluation of the performance of ATLA. ATLA25, 67–69.
12.
GoldbergA.M., van ZutphenL.F.M., & PrincipeM.L. eds (1995). The World Congress on Alternatives and Animal Use in the Life Sciences, 738 pp. New York, USA: Mary Ann Liebert.
13.
Van ZutphenL.F.M., & BallsM. eds (1997). Animal Alternatives, Welfare and Ethics, 1260 pp. Amsterdam, The Netherlands: Elsevier.
14.
Anon. (1999). 3rd World Congress on Alternatives and Animal Use in the Life Sciences. ATLA27, 227–228.
15.
Lane-PetterW. (1961). Provision of Laboratory Animals for Research: a Practical Guide, 147 pp. Amsterdam, The Netherlands: Elsevier.
16.
BurchR.L. (1995). The progress of humane experimental technique since 1959: a personal view. ATLA23, 776–783.
17.
LibowitzL.A. (1998). Letter from CAAT. ATLA26, 577.
18.
NiemiS.M., & WillsonJ.E. eds (1993). Refinement and Reduction in Animal Testing, 138 pp. Bethesda, MD, USA: SCAW.
19.
VenableJ.S. (1997). Preface. The WARDS Journal of Refinement Recognition1, 1–2.
20.
FestingM.F.W. (1998). The FRAME reduction initiative. ATLA26, 377–378.
21.
KozlowskiR. (1998). Chemical wizardry. Oxford Today10 (No. 3), 22–23.
22.
RussellW.M.S. (1995). Speech at the awards luncheon. In The World Congress on Alternatives and Animal Use in the Life Sciences (ed. GoldbergA.M., Van ZutphenL.F.M., & PrincipeM.L.), pp. 71–80. New York, USA: Mary Ann Liebert.
23.
BorchardtR.T., SmithP.L., & WilsonG. eds (1996). Models for Assessing Drug Absorption and Metabolism, 444 pp. New York, USA: Plenum Press.
24.
RussellW.M.S. (1997). A festival of animals. In Animal Alternatives, Welfare and Ethics (ed. Van ZutphenL.F.M., & BallsM.), pp. 9–20. Amsterdam, The Netherlands: Elsevier.
25.
HendriksenC.F.M., & de LeeuwW.A. (1998). Discussion. Research in Immunology149, 611–620.
26.
HendriksenC.F.M., & de LeeuwW.A. (1998). Production of monoclonal antibodies by the ascites method in laboratory animals. Research in Immunology149, 535–542.
27.
De GeusB., & HendriksenC.F.M. (1998). Introduction. Research in Immunology149, 533–534.
28.
HendriksenC.F.M. (1998). A call for a European prohibition of monoclonal antibody production by the ascites procedure in laboratory animals. ATLA26, 523–540.
29.
HendriksenC.F.M. (1988). Laboratory Animals in Vaccine Production and Control: Replacement, Reduction and Refinement (transl. H. Volman), 158 pp. Dordrecht, The Netherlands: Kluwer Academic Publishers.
30.
van der KampM.D.O. (1994). Ways of Replacing, Reducing or Refining the Use of Animals in the Quality Control of Veterinary Vaccines, 107 pp. Lelystad, The Netherlands: Institute for Animal Science and Health.
31.
HarrisonP.F., & RosenfieldA. eds (1996). Contraceptive Research and Development, 519 pp. Washington, DC, USA: National Academy Press.
32.
WeisserK., & HechlerU. (1997). Animal Welfare Aspects in the Quality Control of Immunobiologicals: a Critical Evaluation of the Animal Tests in Pharmacopoeial Monographs (transl. M. Halder), 348 pp. Nottingham, UK: FRAME.
33.
SchnädelbachD. (1997). Foreword. In Animal Welfare Aspects in the Quality Control of Immunobiologicals: A Critical Evaluation of the Animal Tests in Pharmacopoeial Monographs (ed. WeisserK., & HechlerU.; transl. HalderM.), p. 1. Nottingham, UK: FRAME.
34.
LiuM.A., HillemanM.R., & KurthR. eds (1995). DNA Vaccines: A New Era in Vaccinology, 294 pp. New York, USA: New York Academy of Sciences.
35.
LangleyG. (1998). Biopharmaceuticals: from animals or plants?ATLA26, 569–570.
36.
NotarianniE., & EvansM.J. (1992). Transgenesis and genetic engineering in domestic animals. In Transgenesis: Application of Gene Transfer (ed. MurrayJ.A.H.), pp. 251–281. Chichester, UK: John Wiley.
37.
van ZutphenL.F.M., & van der MeerM. eds (1997). Welfare Aspects of Transgenic Animals, 119 pp. Berlin, Germany: Springer-Verlag.
38.
HendriksenC.F.M., & MortonD.B. eds (1999). Humane Endpoints in Animal Experiments for Biomedical Research, 150 pp. London, UK: RSM Press.
39.
WolfE., & WankeR. (1997). Growth hormone overproduction in transgenic mice: phenotypic alterations and deduced animal models. In Welfare Aspects of Transgenic Animals (ed. van ZutphenL.F.M., & van der MeerM.), pp. 26–47. Berlin, Germany: Springer-Verlag.
40.
FlecknellP.A. (1997). Refinement of rodent and rabbit anaesthesia and analgesia. The WARDS Journal of Refinement Recognition1, 7–17.
41.
WilsonS.P., YeomansD.C., BenderM.A., LuY., GoinsW.F., & GloriosoJ.C. (1999). Antihyperalgesic effects of infection with a preproenkephalin-encoding herpes virus. Proceedings of the National Academy of Sciences, USA96, 3211–3216.
42.
HumeC.W. (1957). The strategy and tactics of experimentation. Lancet23 November 1957, 1049–1052.
43.
PiodaL. (1994). The position of the authorities. In Alternatives to Animal Testing (ed. ReinhardtC.A.), pp. 173–176. Weinheim, Germany: VCH Publishers.
Anon. (1999). Many steps too far: proposed increases in laboratory animal use. FRAME News47, 1–2.
46.
BallsM. (1999). The precautionary principle should be used with caution — and should be applied to animal experimentation and genetic manipulation, not merely to protection of the environment. ATLA27, 1–5.
47.
LibowitzL.A. (1999). Letter from CAAT. ATLA27, 37.